Profil bibliographique

Patrycja Gradowska

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

90Publications signalées

2095Citations signalées

0Affiliations récentes

Domaines associés

Acute Myeloid Leukemia ResearchEstrogen and related hormone effectsMicroRNA in disease regulationRNA Research and SplicingCancer-related molecular mechanisms research

Publications récentes

Accès ouvert 2026 article

Treatment of therapy-related acute myeloid leukemia and acute myeloid leukemia with myelodysplasia-related changes: a comparative analysis of higher-dose intensive 7+3 induction chemotherapy versus liposomal cytarabine and daunorubicin

Dimitrios Kotsos, Patrycja Gradowska, Sjoerd J. F. Hermans, Thomas Pabst et autres

0 citationsHaematologica

Accès ouvert 2026 article

Treatment of therapy-related acute myeloid leukemia and acute myeloid leukemia with myelodysplasia-related changes: a comparative analysis of higher-dose intensive 7+3 induction chemotherapy versus liposomal cytarabine and daunorubicin.

Dimitrios Kotsos, Patrycja Gradowska, Sjoerd J F Hermans, Thomas Pabst et autres

0 citationsOpen Access CRIS of the University of Bern

2026 article

Bleximenib or Placebo in Combination with Standard Induction and Consolidation Therapy Followed By Maintenance for the Treatment of Patients with Newly Diagnosed KMT2A-Rearranged or NPM1-Mutant Acute Myeloid Leukemia Eligible for Intensive Chemotherapy: A Double-Blind phase 3 Study (HOVON 181 AML / AMLSG 37-25)

Marc Raaijmakers, Hartmut Döhner, Dimitri A Breems, John C. Byrd et autres

0 citationsTransplantation and Cellular Therapy

Accès ouvert 2025 article

Prognostic relevance of limit of quantification as low-level cutoff for flow cytometry-based measurable residual disease assessment in acute myeloid leukemia

Lukas H. Haaksma, Raffaele Palmieri, Tom Reuvekamp, Jesse M. Tettero et autres

1 citationLeukemia

2025 conference-abstract

Bleximenib or placebo in combination with standard induction and consolidation therapy followed by maintenance for the treatment of patients with newly diagnosed KMT2A-rearranged or NPM1-mutant Acute Myeloid Leukemia eligible for intensive chemotherapy: A double-blind Phase 3 study (HOVON 181 AML / AMLSG 37-25)

Marc H.G.P. Raaijmakers, Hartmut Döhner, Dimitri Breems, John C. Byrd et autres

2 citationsBlood

Accès ouvert 2025 article

Autologous stem cell transplantation versus consolidation chemotherapy as post-remission treatment in newly diagnosed favorable and intermediate risk patients with AML: A comparative analysis of HOVON-SAKK-Nordic trials

Dimitrios Kotsos, Carin Hazenberg, Thomas Pabst, Patrycja Gradowska et autres

0 citationsHemaSphere

Accès ouvert 2025 review

Heart failure in patients with acute myeloid leukemia (AML) treated with anthracycline agents during remission induction therapy: a systematic review and meta-analysis

Jesse Geels, Anna van Rhenen, Patrycja Gradowska, Folkert W. Asselbergs et autres

2 citationsLeukemia

Accès ouvert 2025 article

Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial

Tim R. Mocking, Lukas H. Haaksma, Tom Reuvekamp, Angèle Kelder et autres

0 citationsZurich Open Repository and Archive (University of Zurich)

Accès ouvert 2025 article

Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial

Tim R. Mocking, Lukas H. Haaksma, Tom Reuvekamp, Angèle Kelder et autres

0 citationsLeukemia

Accès ouvert 2025 article

A revised prognostic model for patients with acute myeloid leukemia and first relapse

N Maas, Dimitri A Breems, Clara P. W. Klerk, Thomas Pabst et autres

0 citationsOpen Access CRIS of the University of Bern

Accès ouvert 2025 article

A revised prognostic model for patients with acute myeloid leukemia and first relapse

N Maas, Dimitri Breems, Clara Klerk, Thomas Pabst et autres

2 citationsBlood Advances

Accès ouvert 2025 article

Different features of acute myeloid leukemia stem cell quantification in intensively treated patients

Lok Lam Ngai, Tom Reuvekamp, Diana Hanekamp, Fleur Janssen et autres

2 citationsHaematologica

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.